CU20140122A7 - DGAT1 INHIBITORS OF CYCLIC HEAD OF BRIDGE HEAD - Google Patents
DGAT1 INHIBITORS OF CYCLIC HEAD OF BRIDGE HEADInfo
- Publication number
- CU20140122A7 CU20140122A7 CU2014000122A CU20140122A CU20140122A7 CU 20140122 A7 CU20140122 A7 CU 20140122A7 CU 2014000122 A CU2014000122 A CU 2014000122A CU 20140122 A CU20140122 A CU 20140122A CU 20140122 A7 CU20140122 A7 CU 20140122A7
- Authority
- CU
- Cuba
- Prior art keywords
- head
- cyclic
- bridge
- dgat1 inhibitors
- treatment
- Prior art date
Links
- 229940127193 DGAT1 inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 102100036869 Diacylglycerol O-acyltransferase 1 Human genes 0.000 abstract 1
- 101000927974 Homo sapiens Diacylglycerol O-acyltransferase 1 Proteins 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a los compuestos de la fórmula (I): útiles para el tratamiento de los trastornos mediados por acil-transferasa de acil-CoA-diacil-glicerol 1 ( DGAT1 ), por ejemplo, los trastornos metabólicos. La invención también proporciona métodos para el tratamiento de los trastornos, y los compuestos y las composiciones etc. para su tratamiento.The invention relates to the compounds of the formula (I): useful for the treatment of acyl-CoA-diacyl-glycerol 1 (DGAT1) mediated disorders, for example, metabolic disorders. The invention also provides methods for the treatment of disorders, and the compounds and compositions etc. for your treatment
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361787695P | 2013-03-15 | 2013-03-15 | |
| PCT/IB2013/053292 WO2013160873A1 (en) | 2012-04-27 | 2013-04-25 | Cyclic bridgehead ether dgat1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20140122A7 true CU20140122A7 (en) | 2015-02-26 |
Family
ID=53365655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2014000122A CU20140122A7 (en) | 2013-03-15 | 2014-10-27 | DGAT1 INHIBITORS OF CYCLIC HEAD OF BRIDGE HEAD |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20140122A7 (en) |
-
2014
- 2014-10-27 CU CU2014000122A patent/CU20140122A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140494A (en) | DGAT1 INHIBITORS OF ETER CYCLING HEAD BRIDGE | |
| MX2017002670A (en) | Glycosidase inhibitors. | |
| ECSP16005566A (en) | SULFONAMIDES AS SODIUM CHANNEL MODULATORS | |
| MX373154B (en) | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1). | |
| JO3466B1 (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
| CU24411B1 (en) | COMPOSITE DERIVED FROM BENZAMIDE REPLACED WITH 1,3-TIAZOL-2-ILO USEFUL FOR THE TREATMENT OF NEUROGENIC DISORDERS | |
| MX377273B (en) | CYCLOPROPYLAMINE AS AN INHIBITOR OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1). | |
| MX373103B (en) | CYCLOPROPYLAMINES AS INHIBITORS OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1). | |
| MX2015012456A (en) | Heterocyclic compounds and uses thereof. | |
| CR20150500A (en) | DERIVATIVES OF 3-ACETYLLAMIN-1 (PHENYL-HETEROARIL- AMINOCARBONIL OR PHENYL-HETEROARIL-CARBONYLAMINE) BENZENE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | |
| BR112015004111A2 (en) | new bicyclic derivatives | |
| JO3433B1 (en) | Four-membered ring carboxamide for use as a nematicidal | |
| SV2011003809A (en) | HETEROARILO DERIVATIVES AS DGAT1 INHIBITORS | |
| EA201690844A1 (en) | GSK-3 INHIBITORS | |
| UY33910A (en) | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders | |
| CR20150447A (en) | NEW DERIVATIVES OF PIRAZOL | |
| EA201591360A1 (en) | AZABENZIMADAZLES AS INHIBITORS INHIBITORS PDE4 FOR THE TREATMENT OF THE CNS AND OTHER DISORDERS | |
| CR20150440A (en) | NEW DERIVATIVES OF PIRIDINA | |
| DK3386991T3 (en) | POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINKINASE | |
| CR20140553A (en) | PIPERIDINE PHENOXIETIL COMPOUNDS | |
| CR20180298A (en) | NEW DERIVATIVES OF PHENYL | |
| CR20160459A (en) | NEW DERIVATIVES OF PIRIDINA | |
| NZ742952A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| UY34800A (en) | PHARMACEUTICAL COMBINATIONS CONTAINING AN INHIBITOR OF 11-BETA-HYDROXIESTEROID DEHYDROGENASE-1 USEFUL IN METABOLIC DISORDERS | |
| CR20160448A (en) | NEW DERIVATIVES OF PIRIDINA |